NCT06534060
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06534060
Title MB-105 in Patients With CD5 Positive T-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors March Biosciences Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of San Diego (UCSD)-Moores Cancer Center RECRUITING San Diego California 92037 United States Details
SCRI - Colorado Blood Cancer Institute (CBCI) NOT_YET_RECRUITING Denver Colorado 92037 United States Details
Moffitt Cancer Center Magnolia Campus RECRUITING Tampa Florida 33612 United States Details
University of Iowa RECRUITING Iowa City Iowa 52242 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
University of Nebraska RECRUITING Omaha Nebraska 68198 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
Cleveland Clinic NOT_YET_RECRUITING Cleveland Ohio 44195 United States Details
Oregan Health & Science University NOT_YET_RECRUITING Portland Oregon 97239 United States Details
Baylor College of Medicine RECRUITING Houston Texas 77030 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field